StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of BLPH opened at $0.04 on Friday. The stock has a 50 day simple moving average of $0.04 and a 200 day simple moving average of $0.05. Bellerophon Therapeutics has a 52-week low of $0.03 and a 52-week high of $0.42. The firm has a market capitalization of $428,155.00, a PE ratio of -0.04 and a beta of 0.70.
Bellerophon Therapeutics Company Profile
See Also
- Five stocks we like better than Bellerophon Therapeutics
- Comparing and Trading High PE Ratio Stocks
- The Average 401k Balance by Age Explained
- ESG Stocks, What Investors Should Know
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Why is the Ex-Dividend Date Significant to Investors?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.